Baricitinib Therapy in COVID-19: A Pilot Study on Safety and Clinical Impact
Latest Information Update: 07 Jul 2020
At a glance
- Drugs Baricitinib (Primary) ; Lopinavir/ritonavir (Primary)
- Indications COVID 2019 infections; Pneumonia
- Focus Adverse reactions
Most Recent Events
- 24 Jun 2020 Results published in the Journal of Infection
- 27 Apr 2020 New trial record